Search

Your search keyword '"Iwadate M"' showing total 84 results

Search Constraints

Start Over You searched for: Author "Iwadate M" Remove constraint Author: "Iwadate M"
84 results on '"Iwadate M"'

Search Results

2. No increase in translocated chromosomal aberrations, an indicator of ionizing radiation exposure, in childhood thyroid cancer in Fukushima Prefecture

7. Potential implications of thyroid autoantibodies in children, adolescents, and young adults with thyroid nodules in Japan: The Fukushima Health Management Survey.

8. Prevalence of thyroid diffuse goiter and its association with body mass index and the presence of cysts and nodules in children and adolescents: the Fukushima Health Management Survey.

9. Effects of Overweight on Risk of Thyroid Nodules in Children and Adolescents: The Fukushima Health Management Survey.

10. [A Patient with Cancer of Unknown Primary Who Responded to Chemotherapy].

11. Confounding factors and biases involved in regional differences in the detection rate of thyroid cancer in the second-round Thyroid Ultrasound Examination: the Fukushima Health Management Survey.

12. Analysis of Expression of Programmed Cell Death Ligand 1 (PD-L1) and BRAF V600E Mutation in Thyroid Cancer.

13. Ultrasonography-based reference values for the cross-sectional area of the thyroid gland in children and adolescents: The Fukushima Health Management Survey.

14. Possible Association Between Thyroid Nodule Formation and Developmental Alterations in the Pituitary-Thyroid Hormone Axis in Children and Adolescents: The Fukushima Health Management Survey.

15. A Comprehensive Review of the Progress and Evaluation of the Thyroid Ultrasound Examination Program, the Fukushima Health Management Survey.

16. Revisiting the Geographical Distribution of Thyroid Cancer Incidence in Fukushima Prefecture: Analysis of Data From the Second- and Third-round Thyroid Ultrasound Examination.

17. Fine Needle Aspiration Cytology Implementation and Malignancy Rates in Children and Adolescents Based on Japanese Guidelines: The Fukushima Health Management Survey.

18. Papillary Thyroid Carcinoma in Ukraine After Chernobyl and in Japan After Fukushima: Different Histopathological Scenarios.

19. Psychosocial support for the examinees and their families during the secondary confirmatory examination:Analyses of support records at first visit.

20. Cytological examination of the thyroid in children and adolescents after the Fukushima Nuclear Power Plant accident: the Fukushima Health Management Survey.

21. The Clinicopathological Results of Thyroid Cancer With BRAFV600E Mutation in the Young Population of Fukushima.

22. Time-dependent changes in FT4 and FT3 levels measured using mass spectrometry after an acute ingestion of excess levothyroxine in a case with hypothyroidism.

24. Absorbed radiation doses in the thyroid as estimated by UNSCEAR and subsequent risk of childhood thyroid cancer following the Great East Japan Earthquake.

25. Evaluation of the 8th Edition TNM Classification for Anaplastic Thyroid Carcinoma.

26. Investigation of thyroid cancer cases that were not detected in the Thyroid Ultrasound Examination program of the Fukushima Health Management Survey but diagnosed at Fukushima Medical University Hospital.

27. Development of a novel anti-hepatitis B virus agent via Sp1.

28. A prospective compound screening contest identified broader inhibitors for Sirtuin 1.

29. Histopathological analysis of papillary thyroid carcinoma detected during ultrasound screening examinations in Fukushima.

30. Prognostic impact of elevated preoperative C-reactive protein on patients with differentiated thyroid carcinoma.

31. An in vivo model for thyroid regeneration and folliculogenesis.

32. Metastasis of breast cancer cells to the bone, lung, and lymph nodes promotes resistance to ionizing radiation.

33. An iterative compound screening contest method for identifying target protein inhibitors using the tyrosine-protein kinase Yes.

34. An Adult Mouse Thyroid Side Population Cell Line that Exhibits Enriched Epithelial-Mesenchymal Transition.

35. SFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancer.

36. Molecular Dynamics Simulations to Determine the Structure and Dynamics of Hepatitis B Virus Capsid Bound to a Novel Anti-viral Drug.

37. Identification of potential inhibitors based on compound proposal contest: Tyrosine-protein kinase Yes as a target.

38. [Game addiction].

39. Development of novel hepatitis B virus capsid inhibitor using in silico screening.

40. Principal component analysis-based unsupervised feature extraction applied to in silico drug discovery for posttraumatic stress disorder-mediated heart disease.

41. Discovering novel direct acting antiviral agents for HBV using in silico screening.

42. [An inflammatory pseudotumor of the liver mimicking a metastatic lesion of gallbladder cancer - a case report].

43. TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasis in non-small cell lung cancer.

44. Genes associated with genotype-specific DNA methylation in squamous cell carcinoma as candidate drug targets.

45. Bioinformatic screening of autoimmune disease genes and protein structure prediction with FAMS for drug discovery.

46. Community-wide evaluation of methods for predicting the effect of mutations on protein-protein interactions.

47. [A case of a giant rectal gastrointestinal stromal tumor radically resectable after treatment with neoadjuvant imatinib mesylate].

48. Cathepsin L is highly expressed in gastrointestinal stromal tumors.

49. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells.

50. The importance of the macroscopic classification of colorectal neoplasms.

Catalog

Books, media, physical & digital resources